GSK-104871

Study Sponsor: GSK

Study Title

A multicentric study to compare the immunogenicity, safety & reactogenicity of GSK Biologicals' DTPa-IPV vaccine vs. co-administration of GSK's DTPa vaccine & Sanofi-Pasteurs' IPV vaccine at different injection sites, to healthy children

Medicine or Vaccine (generic name)

Diphtheria, Tetanus, Acellular Pertussis Vaccine Adsorbed

Sponsor Identification Number

104871

Trial Registry Identification Number(#'s)

NCT00290342 2015-001508-71

Medical Condition

Acellular pertussis; Diphtheria; Tetanus

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=104871

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00290342

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2015-001508-71

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

September 2013